InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Browse the detailed record of transactions filed by Ruffo Frank, Chief Financial Officer. Insider active across 1 companies, notably Aclaris Therapeutics, Inc.. Aggregated, 8 reports have been logged. Total volume traded: €211k. The latest transaction was filed on 10 March 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
€180,00512,823 shares@ €14.03770.029% mcap85.4% of flow
Common Stock
SEC:0001209191-22-018509:0·
25,750 shares
Common Stock
SEC:0001209191-22-015809:0·
€15,3821,388 shares@ €11.08230.0024% mcap100.0% of flow
Common Stock
SEC:0001209191-22-008849·
€15,3821,388 shares@ €11.08230.0024% mcap7.3% of flow
Common Stock
SEC:0001209191-22-008849:0·
3,875 shares
Common Stock
SEC:0001209191-22-006832·
3,875 shares
Common Stock
SEC:0001209191-22-006832:0·
33,189 shares
Common Stock
SEC:0001209191-21-037475·
33,189 shares
Common Stock
SEC:0001209191-21-037475:0·
8 of 8 declarations
About Ruffo Frank
Frank Ruffo is the Chief Financial Officer at Aclaris Therapeutics, Inc. He is responsible for the financial management of the company, including budgeting and financial analysis. His role is essential in ensuring the financial health of the organization.
